25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Fisher & Paykel Healthcare Corporation Limited
Buy, Hold or Sell?

Let's analyze Fisher & Paykel Healthcare Corporation Limited together

I guess you are interested in Fisher & Paykel Healthcare Corporation Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Fisher & Paykel Healthcare Corporation Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Fisher & Paykel Healthcare Corporation Limited

I send you an email if I find something interesting about Fisher & Paykel Healthcare Corporation Limited.

1. Quick Overview

1.1. Quick analysis of Fisher & Paykel Healthcare Corporation Limited (30 sec.)










1.2. What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited? (30 sec.)

How much money do you get?

How much money do you get?
A$0.57
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
A$2.71
Expected worth in 1 year
A$3.43
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
A$1.62
Return On Investment
5.1%

For what price can you sell your share?

Current Price per Share
A$31.79
Expected price per share
A$29.20 - A$33.76
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Fisher & Paykel Healthcare Corporation Limited (5 min.)




Live pricePrice per Share (EOD)
A$31.79
Intrinsic Value Per Share
A$-4.80 - A$2.17
Total Value Per Share
A$-2.09 - A$4.88

2.2. Growth of Fisher & Paykel Healthcare Corporation Limited (5 min.)




Is Fisher & Paykel Healthcare Corporation Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$940.5m$67.6m6.7%

How much money is Fisher & Paykel Healthcare Corporation Limited making?

Current yearPrevious yearGrowGrow %
Making money$75.9m$143.4m-$67.4m-88.8%
Net Profit Margin7.6%16.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Fisher & Paykel Healthcare Corporation Limited (5 min.)




2.4. Comparing to competitors in the Medical Instruments & Supplies industry (5 min.)




  Industry Rankings (Medical Instruments & Supplies)  


Richest
#47 / 165

Most Revenue
#23 / 165

Most Profit
#22 / 165
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Fisher & Paykel Healthcare Corporation Limited?

Welcome investor! Fisher & Paykel Healthcare Corporation Limited's management wants to use your money to grow the business. In return you get a share of Fisher & Paykel Healthcare Corporation Limited.

First you should know what it really means to hold a share of Fisher & Paykel Healthcare Corporation Limited. And how you can make/lose money.

Speculation

The Price per Share of Fisher & Paykel Healthcare Corporation Limited is A$31.79. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Fisher & Paykel Healthcare Corporation Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Fisher & Paykel Healthcare Corporation Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$2.71. Based on the TTM, the Book Value Change Per Share is A$0.18 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.13 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.22 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Fisher & Paykel Healthcare Corporation Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.130.4%0.130.4%0.240.8%0.311.0%0.230.7%
Usd Book Value Change Per Share0.120.4%0.120.4%0.080.3%0.170.5%0.130.4%
Usd Dividend Per Share0.140.4%0.140.4%0.190.6%0.170.5%0.130.4%
Usd Total Gains Per Share0.260.8%0.260.8%0.270.9%0.351.1%0.260.8%
Usd Price Per Share15.04-15.04-15.80-16.42-11.48-
Price to Earnings Ratio116.00-116.00-64.56-64.19-52.08-
Price-to-Total Gains Ratio58.41-58.41-57.51-54.43-47.74-
Price to Book Ratio8.74-8.74-9.85-12.30-11.40-
Price-to-Total Gains Ratio58.41-58.41-57.51-54.43-47.74-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.205724
Number of shares49
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.140.17
Usd Book Value Change Per Share0.120.17
Usd Total Gains Per Share0.260.35
Gains per Quarter (49 shares)12.6217.02
Gains per Year (49 shares)50.4768.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1282340343458
25645906968126
38468140103101194
411290190137135262
5139113240171169330
6167136290206203398
7195158340240237466
8223181390274271534
9251203440308304602
10279226490343338670

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%22.03.00.088.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%25.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%24.01.00.096.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Fisher & Paykel Healthcare Corporation Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.1810.1810%0.131+38%0.271-33%0.208-13%
Book Value Per Share--2.7062.7060%2.525+7%2.245+21%1.609+68%
Current Ratio--1.8311.8310%2.671-31%2.225-18%2.236-18%
Debt To Asset Ratio--0.2290.2290%0.205+12%0.245-7%0.256-11%
Debt To Equity Ratio--0.2970.2970%0.257+15%0.329-10%0.348-15%
Dividend Per Share--0.2240.2240%0.301-26%0.275-19%0.203+11%
Enterprise Value--13471704558.44013471704558.4400%14292821367.190-6%14903354887.059-10%10401063149.473+30%
Eps--0.2040.2040%0.385-47%0.483-58%0.369-45%
Ev To Ebitda Ratio--33.58933.5890%36.548-8%31.967+5%28.106+20%
Ev To Sales Ratio--8.5738.5730%10.660-20%10.853-21%9.314-8%
Free Cash Flow Per Share--0.1390.1390%0.018+684%0.235-41%0.200-30%
Free Cash Flow To Equity Per Share---0.059-0.0590%-0.285+387%-0.045-24%-0.005-92%
Gross Profit Margin---2.716-2.7160%-0.726-73%-0.684-75%-0.639-76%
Intrinsic Value_10Y_max--2.175--------
Intrinsic Value_10Y_min---4.799--------
Intrinsic Value_1Y_max--0.232--------
Intrinsic Value_1Y_min---0.032--------
Intrinsic Value_3Y_max--0.686--------
Intrinsic Value_3Y_min---0.486--------
Intrinsic Value_5Y_max--1.127--------
Intrinsic Value_5Y_min---1.363--------
Market Cap18633359064.320+26%13868993578.44013868993578.4400%14571415738.880-5%15146020896.552-8%10588695644.436+31%
Net Profit Margin--0.0760.0760%0.168-55%0.204-63%0.201-62%
Operating Margin--0.2030.2030%0.225-10%0.294-31%0.286-29%
Operating Ratio--0.7970.7970%0.786+1%0.728+10%0.741+8%
Pb Ratio11.748+26%8.7448.7440%9.847-11%12.301-29%11.397-23%
Pe Ratio155.853+26%115.995115.9950%64.562+80%64.195+81%52.082+123%
Price Per Share31.790+26%23.66023.6600%24.860-5%25.840-8%18.065+31%
Price To Free Cash Flow Ratio228.103+26%169.768169.7680%1398.600-88%372.512-54%217.958-22%
Price To Total Gains Ratio78.475+26%58.40558.4050%57.511+2%54.433+7%47.737+22%
Quick Ratio--0.8810.8810%1.082-19%1.498-41%1.590-45%
Return On Assets--0.0580.0580%0.121-52%0.171-66%0.182-68%
Return On Equity--0.0750.0750%0.153-51%0.230-67%0.247-69%
Total Gains Per Share--0.4050.4050%0.432-6%0.546-26%0.411-1%
Usd Book Value--1008176306.7321008176306.7320%940571258.927+7%836507450.704+21%599314356.630+68%
Usd Book Value Change Per Share--0.1150.1150%0.083+38%0.173-33%0.132-13%
Usd Book Value Per Share--1.7201.7200%1.605+7%1.427+21%1.022+68%
Usd Dividend Per Share--0.1420.1420%0.191-26%0.175-19%0.129+11%
Usd Enterprise Value--8562615417.3448562615417.3440%9084517260.986-6%9472572366.215-10%6610915737.805+30%
Usd Eps--0.1300.1300%0.245-47%0.307-58%0.234-45%
Usd Free Cash Flow--51924719.11251924719.1120%6622043.677+684%87495174.705-41%74505842.516-30%
Usd Free Cash Flow Per Share--0.0890.0890%0.011+684%0.149-41%0.127-30%
Usd Free Cash Flow To Equity Per Share---0.037-0.0370%-0.181+387%-0.028-24%-0.003-92%
Usd Market Cap11843363021.282+26%8815132318.4568815132318.4560%9261591843.632-5%9626810881.848-8%6730174951.604+31%
Usd Price Per Share20.206+26%15.03815.0380%15.801-5%16.424-8%11.482+31%
Usd Profit--75995780.95275995780.9520%143452066.156-47%180108854.615-58%137345467.015-45%
Usd Revenue--998834442.256998834442.2560%852168074.367+17%891299033.052+12%681542819.053+47%
Usd Total Gains Per Share--0.2570.2570%0.275-6%0.347-26%0.261-1%
 EOD+4 -4MRQTTM+0 -0YOY+15 -255Y+11 -2910Y+17 -23

3.3 Fundamental Score

Let's check the fundamental score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15155.853
Price to Book Ratio (EOD)Between0-111.748
Net Profit Margin (MRQ)Greater than00.076
Operating Margin (MRQ)Greater than00.203
Quick Ratio (MRQ)Greater than10.881
Current Ratio (MRQ)Greater than11.831
Debt to Asset Ratio (MRQ)Less than10.229
Debt to Equity Ratio (MRQ)Less than10.297
Return on Equity (MRQ)Greater than0.150.075
Return on Assets (MRQ)Greater than0.050.058
Total6/10 (60.0%)

3.4 Technical Score

Let's check the technical score of Fisher & Paykel Healthcare Corporation Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5038.428
Ma 20Greater thanMa 5032.862
Ma 50Greater thanMa 10033.680
Ma 100Greater thanMa 20033.566
OpenGreater thanClose32.130
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, it provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP) therapy, and nasal high flow therapy products. Further, the company offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Fundamental data was last updated by Penke on 2025-02-08 23:12:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Fisher & Paykel Healthcare Corporation Limited earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Net Profit Margin of 7.6% means that $0.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 7.6%. The company is making a profit. +1
  • The TTM is 7.6%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ7.6%TTM7.6%0.0%
TTM7.6%YOY16.8%-9.2%
TTM7.6%5Y20.4%-12.7%
5Y20.4%10Y20.1%+0.2%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ7.6%5.2%+2.4%
TTM7.6%4.7%+2.9%
YOY16.8%6.5%+10.3%
5Y20.4%6.9%+13.5%
10Y20.1%7.4%+12.7%
4.3.1.2. Return on Assets

Shows how efficient Fisher & Paykel Healthcare Corporation Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • 5.8% Return on Assets means that Fisher & Paykel Healthcare Corporation Limited generated $0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 5.8%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.8%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.8%TTM5.8%0.0%
TTM5.8%YOY12.1%-6.3%
TTM5.8%5Y17.1%-11.3%
5Y17.1%10Y18.2%-1.1%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ5.8%0.9%+4.9%
TTM5.8%0.8%+5.0%
YOY12.1%1.4%+10.7%
5Y17.1%1.6%+15.5%
10Y18.2%1.6%+16.6%
4.3.1.3. Return on Equity

Shows how efficient Fisher & Paykel Healthcare Corporation Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • 7.5% Return on Equity means Fisher & Paykel Healthcare Corporation Limited generated $0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 7.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 7.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ7.5%TTM7.5%0.0%
TTM7.5%YOY15.3%-7.7%
TTM7.5%5Y23.0%-15.5%
5Y23.0%10Y24.7%-1.7%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ7.5%1.9%+5.6%
TTM7.5%1.5%+6.0%
YOY15.3%2.6%+12.7%
5Y23.0%3.1%+19.9%
10Y24.7%3.2%+21.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Fisher & Paykel Healthcare Corporation Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Fisher & Paykel Healthcare Corporation Limited is operating .

  • Measures how much profit Fisher & Paykel Healthcare Corporation Limited makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • An Operating Margin of 20.3% means the company generated $0.20  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 20.3%. The company is operating efficient. +1
  • The TTM is 20.3%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ20.3%TTM20.3%0.0%
TTM20.3%YOY22.5%-2.2%
TTM20.3%5Y29.4%-9.1%
5Y29.4%10Y28.6%+0.8%
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ20.3%8.1%+12.2%
TTM20.3%7.2%+13.1%
YOY22.5%8.6%+13.9%
5Y29.4%9.5%+19.9%
10Y28.6%9.3%+19.3%
4.3.2.2. Operating Ratio

Measures how efficient Fisher & Paykel Healthcare Corporation Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • An Operation Ratio of 0.80 means that the operating costs are $0.80 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.797. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.797. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.797TTM0.7970.000
TTM0.797YOY0.786+0.011
TTM0.7975Y0.728+0.069
5Y0.72810Y0.741-0.013
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7971.054-0.257
TTM0.7971.076-0.279
YOY0.7861.001-0.215
5Y0.7281.021-0.293
10Y0.7410.999-0.258
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Fisher & Paykel Healthcare Corporation Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A Current Ratio of 1.83 means the company has $1.83 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 1.831. The company is able to pay all its short-term debts. +1
  • The TTM is 1.831. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.831TTM1.8310.000
TTM1.831YOY2.671-0.841
TTM1.8315Y2.225-0.394
5Y2.22510Y2.236-0.011
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8312.062-0.231
TTM1.8312.156-0.325
YOY2.6712.471+0.200
5Y2.2252.654-0.429
10Y2.2362.606-0.370
4.4.3.2. Quick Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Quick Ratio of 0.88 means the company can pay off $0.88 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.881. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.881. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.881TTM0.8810.000
TTM0.881YOY1.082-0.200
TTM0.8815Y1.498-0.617
5Y1.49810Y1.590-0.092
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8810.981-0.100
TTM0.8811.062-0.181
YOY1.0821.229-0.147
5Y1.4981.482+0.016
10Y1.5901.607-0.017
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Fisher & Paykel Healthcare Corporation Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Fisher & Paykel Healthcare Corporation Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to Medical Instruments & Supplies industry mean.
  • A Debt to Asset Ratio of 0.23 means that Fisher & Paykel Healthcare Corporation Limited assets are financed with 22.9% credit (debt) and the remaining percentage (100% - 22.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.229. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.229. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.229TTM0.2290.000
TTM0.229YOY0.205+0.024
TTM0.2295Y0.245-0.016
5Y0.24510Y0.256-0.011
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2290.385-0.156
TTM0.2290.358-0.129
YOY0.2050.344-0.139
5Y0.2450.365-0.120
10Y0.2560.376-0.120
4.5.4.2. Debt to Equity Ratio

Measures if Fisher & Paykel Healthcare Corporation Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A Debt to Equity ratio of 29.7% means that company has $0.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The MRQ is 0.297. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.297. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.297TTM0.2970.000
TTM0.297YOY0.257+0.040
TTM0.2975Y0.329-0.032
5Y0.32910Y0.348-0.019
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2970.566-0.269
TTM0.2970.538-0.241
YOY0.2570.519-0.262
5Y0.3290.587-0.258
10Y0.3480.663-0.315
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Fisher & Paykel Healthcare Corporation Limited generates.

  • Above 15 is considered overpriced but always compare Fisher & Paykel Healthcare Corporation Limited to the Medical Instruments & Supplies industry mean.
  • A PE ratio of 116.00 means the investor is paying $116.00 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 155.853. Based on the earnings, the company is expensive. -2
  • The MRQ is 115.995. Based on the earnings, the company is expensive. -2
  • The TTM is 115.995. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD155.853MRQ115.995+39.858
MRQ115.995TTM115.9950.000
TTM115.995YOY64.562+51.433
TTM115.9955Y64.195+51.800
5Y64.19510Y52.082+12.113
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD155.85316.710+139.143
MRQ115.99516.324+99.671
TTM115.99516.469+99.526
YOY64.56219.479+45.083
5Y64.19521.866+42.329
10Y52.08225.887+26.195
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 228.103. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is 169.768. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 169.768. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD228.103MRQ169.768+58.335
MRQ169.768TTM169.7680.000
TTM169.768YOY1,398.600-1,228.833
TTM169.7685Y372.512-202.745
5Y372.51210Y217.958+154.554
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD228.1039.951+218.152
MRQ169.76810.731+159.037
TTM169.7688.044+161.724
YOY1,398.6000.237+1,398.363
5Y372.5125.260+367.252
10Y217.958-0.362+218.320
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Fisher & Paykel Healthcare Corporation Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Instruments & Supplies industry mean).
  • A PB ratio of 8.74 means the investor is paying $8.74 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Fisher & Paykel Healthcare Corporation Limited:

  • The EOD is 11.748. Based on the equity, the company is expensive. -2
  • The MRQ is 8.744. Based on the equity, the company is overpriced. -1
  • The TTM is 8.744. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD11.748MRQ8.744+3.004
MRQ8.744TTM8.7440.000
TTM8.744YOY9.847-1.103
TTM8.7445Y12.301-3.558
5Y12.30110Y11.397+0.904
Compared to industry (Medical Instruments & Supplies)
PeriodCompanyIndustry (mean)+/- 
EOD11.7482.653+9.095
MRQ8.7442.625+6.119
TTM8.7442.733+6.011
YOY9.8472.780+7.067
5Y12.3013.856+8.445
10Y11.3974.377+7.020
4.6.2. Total Gains per Share

2.4. Latest News of Fisher & Paykel Healthcare Corporation Limited

Does Fisher & Paykel Healthcare Corporation Limited still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Fisher & Paykel Healthcare Corporation Limited to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-02-06
20:42
Fisher & Paykel Healthcare Corporation Limited's (NZSE:FPH) institutional investors lost 8.5% last week but have benefitted from longer-term gainsRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Fisher & Paykel Healthcare Corporation Limited.

4.8.2. Funds holding Fisher & Paykel Healthcare Corporation Limited

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2020-10-31Vanguard International Stock Index-Total Intl Stock Indx1.52-8750473--
2021-01-31Price (T.Rowe) International Discovery Fund0.93-5372634--
2020-12-31Smallcap World Fund0.82-4716500--
2020-12-31Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund0.63-3623676--
2021-01-31Invesco Oppenheimer International Small-Mid Company Fund0.49-2848208--
2020-12-31New Perspective Fund Inc0.47-2699000--
2021-02-28iShares Core MSCI EAFE ETF0.45-2606298--
2020-12-31American Funds Insurance Ser-Global Growth Fund0.44-2550000--
2020-12-31Columbia Acorn International Fund0.34999999-2013595--
2021-02-28iShares MSCI Eafe ETF0.33000002-1902697--
Total 6.4300000103708308100.0%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in NZD. All numbers in thousands.

Summary
Total Assets2,281,700
Total Liabilities522,600
Total Stockholder Equity1,759,100
 As reported
Total Liabilities 522,600
Total Stockholder Equity+ 1,759,100
Total Assets = 2,281,700

Assets

Total Assets2,281,700
Total Current Assets704,900
Long-term Assets1,576,800
Total Current Assets
Cash And Cash Equivalents 82,000
Net Receivables 257,200
Inventory 320,400
Other Current Assets 45,300
Total Current Assets  (as reported)704,900
Total Current Assets  (calculated)704,900
+/-0
Long-term Assets
Property Plant Equipment 1,340,000
Intangible Assets 88,400
Long-term Assets Other 148,400
Long-term Assets  (as reported)1,576,800
Long-term Assets  (calculated)1,576,800
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities385,000
Long-term Liabilities137,600
Total Stockholder Equity1,759,100
Total Current Liabilities
Short-term Debt 96,200
Short Long Term Debt 78,500
Accounts payable 32,400
Other Current Liabilities 256,400
Total Current Liabilities  (as reported)385,000
Total Current Liabilities  (calculated)463,500
+/- 78,500
Long-term Liabilities
Long term Debt 35,700
Capital Lease Obligations 74,900
Long-term Liabilities  (as reported)137,600
Long-term Liabilities  (calculated)110,600
+/- 27,000
Total Stockholder Equity
Common Stock404,000
Retained Earnings 1,095,000
Accumulated Other Comprehensive Income 260,100
Total Stockholder Equity (as reported)1,759,100
Total Stockholder Equity (calculated)1,759,100
+/-0
Other
Capital Stock404,000
Cash and Short Term Investments 82,000
Common Stock Shares Outstanding 586,179
Liabilities and Stockholders Equity 2,281,700
Net Debt 107,100
Net Invested Capital 1,873,300
Net Working Capital 319,900
Property Plant and Equipment Gross 1,899,700
Short Long Term Debt Total 189,100



5.2. Balance Sheets Structured

Currency in NZD. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-312009-03-312008-03-312007-03-312006-03-312005-03-312004-03-312003-03-312002-03-312001-03-312000-03-31
> Total Assets 
459,219
236,686
215,333
228,752
224,173
230,310
267,470
274,667
331,667
413,737
475,059
517,608
572,054
618,597
630,325
669,816
692,093
804,744
964,083
1,158,540
1,389,979
1,907,996
1,951,645
2,063,359
2,281,700
2,281,7002,063,3591,951,6451,907,9961,389,9791,158,540964,083804,744692,093669,816630,325618,597572,054517,608475,059413,737331,667274,667267,470230,310224,173228,752215,333236,686459,219
   > Total Current Assets 
221,164
163,137
140,582
133,773
122,521
127,658
125,339
118,180
129,574
172,675
180,065
186,487
195,031
215,157
234,958
243,291
257,882
319,889
398,950
437,129
502,427
845,955
822,433
724,633
704,900
704,900724,633822,433845,955502,427437,129398,950319,889257,882243,291234,958215,157195,031186,487180,065172,675129,574118,180125,339127,658122,521133,773140,582163,137221,164
       Cash And Cash Equivalents 
2,622
102,174
73,310
13,336
30,578
23,057
16,554
7,742
5,263
5,465
6,891
6,110
6,253
7,709
10,438
13,621
16,915
56,128
30,001
46,276
64,995
89,469
83,271
113,253
82,000
82,000113,25383,27189,46964,99546,27630,00156,12816,91513,62110,4387,7096,2536,1106,8915,4655,2637,74216,55423,05730,57813,33673,310102,1742,622
       Short-term Investments 
0
0
0
35,000
17,000
14,000
12,000
0
2,865
6,256
21,443
14,871
21,050
28,360
33,141
23,776
11,546
19,396
112,105
88,808
75,262
257,740
185,253
500
0
0500185,253257,74075,26288,808112,10519,39611,54623,77633,14128,36021,05014,87121,4436,2562,865012,00014,00017,00035,000000
       Net Receivables 
90,789
34,100
41,752
52,824
41,345
54,585
55,367
58,452
60,262
80,996
71,437
79,622
77,130
81,560
84,747
95,713
120,257
120,672
138,908
152,942
216,294
210,477
142,800
179,600
257,200
257,200179,600142,800210,477216,294152,942138,908120,672120,25795,71384,74781,56077,13079,62271,43780,99660,26258,45255,36754,58541,34552,82441,75234,10090,789
       Inventory 
72,907
18,270
19,216
21,852
24,076
30,906
36,190
46,697
50,770
69,946
71,763
80,101
84,430
89,111
94,475
96,143
109,164
123,693
117,936
130,668
141,904
248,821
332,437
342,380
320,400
320,400342,380332,437248,821141,904130,668117,936123,693109,16496,14394,47589,11184,43080,10171,76369,94650,77046,69736,19030,90624,07621,85219,21618,27072,907
       Other Current Assets 
54,846
8,593
6,304
10,761
9,522
5,110
5,228
5,289
13,279
16,268
29,974
20,654
27,218
36,777
45,298
37,814
1,692
1,866
0
18,434
3,971
39,447
30,733
107,300
45,300
45,300107,30030,73339,4473,97118,43401,8661,69237,81445,29836,77727,21820,65429,97416,26813,2795,2895,2285,1109,52210,7616,3048,59354,846
   > Long-term Assets 
0
73,549
74,751
94,979
101,652
102,652
142,131
156,487
202,093
241,062
294,994
331,121
377,023
403,440
395,367
426,525
434,211
484,855
565,133
721,411
887,552
1,062,041
1,129,213
1,338,727
1,576,800
1,576,8001,338,7271,129,2131,062,041887,552721,411565,133484,855434,211426,525395,367403,440377,023331,121294,994241,062202,093156,487142,131102,652101,65294,97974,75173,5490
       Property Plant Equipment 
177,667
58,914
64,917
71,448
71,545
82,899
128,296
141,885
186,489
204,558
233,278
254,265
311,631
346,716
349,760
367,428
351,649
389,602
448,043
577,398
712,231
811,105
887,179
1,074,688
1,340,000
1,340,0001,074,688887,179811,105712,231577,398448,043389,602351,649367,428349,760346,716311,631254,265233,278204,558186,489141,885128,29682,89971,54571,44864,91758,914177,667
       Goodwill 
1,657
2,955
1,133
2,185
1,800
1,415
1,030
645
1,030
1,030
1,030
1,030
1,030
1,450
1,450
1,450
0
0
0
0
0
0
0
0
0
0000000001,4501,4501,4501,0301,0301,0301,0301,0306451,0301,4151,8002,1851,1332,9551,657
       Long Term Investments 
56,740
45,568
-889
0
0
0
0
0
0
0
0
0
0
0
777
17
10
22,059
900
400
0
0
0
0
0
0000040090022,059101777700000000000-88945,56856,740
       Intangible Assets 
0
0
2,570
3,949
4,032
2,382
2,255
2,231
4,287
4,469
4,891
5,390
5,396
7,176
8,955
20,980
32,273
40,755
47,400
59,046
71,581
73,561
80,400
80,120
88,400
88,40080,12080,40073,56171,58159,04647,40040,75532,27320,9808,9557,1765,3965,3904,8914,4694,2872,2312,2552,3824,0323,9492,57000
       Long-term Assets Other 
0
11,680
7,264
11,827
934
0
261
1,388
1,142
4,162
11,566
17,709
11,878
8,592
3,304
3,628
0
0
0
0
0
0
0
0
148,400
148,400000000003,6283,3048,59211,87817,70911,5664,1621,1421,388261093411,8277,26411,6800
> Total Liabilities 
267,796
84,592
43,450
35,935
32,948
38,279
63,477
81,153
136,003
209,436
181,895
204,317
223,902
246,366
224,203
198,626
203,199
198,454
248,004
281,786
446,731
509,504
395,794
422,219
522,600
522,600422,219395,794509,504446,731281,786248,004198,454203,199198,626224,203246,366223,902204,317181,895209,436136,00381,15363,47738,27932,94835,93543,45084,592267,796
   > Total Current Liabilities 
152,655
62,702
41,760
34,766
30,433
37,356
62,341
80,117
110,381
93,854
97,812
84,178
150,623
91,068
128,790
117,114
134,955
133,404
167,781
177,040
324,102
393,093
281,493
271,246
385,000
385,000271,246281,493393,093324,102177,040167,781133,404134,955117,114128,79091,068150,62384,17897,81293,854110,38180,11762,34137,35630,43334,76641,76062,702152,655
       Short-term Debt 
94,465
8,586
7,454
3,106
6,326
8,065
23,841
40,845
65,007
23,447
24,502
17,110
80,230
17,136
45,786
15,528
14,699
19,327
28,120
16,610
89,307
24,459
17,000
21,300
96,200
96,20021,30017,00024,45989,30716,61028,12019,32714,69915,52845,78617,13680,23017,11024,50223,44765,00740,84523,8418,0656,3263,1067,4548,58694,465
       Short Long Term Debt 
94,465
77,052
2,727
0
0
0
0
0
0
0
0
0
0
0
112,740
1,374
2,105
21,091
29,900
17,300
80,600
11,900
5,300
4,200
78,500
78,5004,2005,30011,90080,60017,30029,90021,0912,1051,374112,740000000000002,72777,05294,465
       Accounts payable 
26,468
8,496
8,367
8,677
10,810
15,075
19,173
15,907
14,660
23,677
22,812
21,117
22,506
21,139
23,221
27,663
33,362
26,868
30,754
52,901
67,126
52,137
53,800
43,000
32,400
32,40043,00053,80052,13767,12652,90130,75426,86833,36227,66323,22121,13922,50621,11722,81223,67714,66015,90719,17315,07510,8108,6778,3678,49626,468
       Other Current Liabilities 
31,722
4,814
11,205
22,983
13,297
14,216
19,327
11,442
30,714
46,730
50,498
45,951
47,887
52,793
4,693
73,923
69,640
73,744
88,217
84,104
133,380
178,938
181,145
219,323
256,400
256,400219,323181,145178,938133,38084,10488,21773,74469,64073,9234,69352,79347,88745,95150,49846,73030,71411,44219,32714,21613,29722,98311,2054,81431,722
   > Long-term Liabilities 
0
21,890
1,690
1,169
2,515
923
1,136
1,036
25,622
115,582
84,083
120,139
73,279
155,298
95,413
81,512
68,244
65,049
80,223
104,746
122,628
116,411
114,301
150,973
137,600
137,600150,973114,301116,411122,628104,74680,22365,04968,24481,51295,413155,29873,279120,13984,083115,58225,6221,0361,1369232,5151,1691,69021,8900
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
46,853
39,950
52,500
69,000
44,000
91,800
0
0
0
00091,80044,00069,00052,50039,95046,8530000000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,600
43,700
36,000
62,500
74,900
74,90062,50036,00043,70033,60000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,297
0
0
0
0
0
0
0
000000014,29700000000000000000
> Total Stockholder Equity
191,423
152,094
171,883
192,817
191,225
192,031
203,993
193,514
195,664
204,301
293,164
313,291
348,152
372,231
406,122
471,190
488,894
606,290
716,079
876,754
943,248
1,398,492
1,555,851
1,641,140
1,759,100
1,759,1001,641,1401,555,8511,398,492943,248876,754716,079606,290488,894471,190406,122372,231348,152313,291293,164204,301195,664193,514203,993192,031191,225192,817171,883152,094191,423
   Common Stock
0
152,094
171,883
172,724
170,607
192,031
203,993
193,514
3,647
4,076
13,000
38,719
63,305
91,280
120,373
145,871
149,500
168,146
189,412
212,180
221,815
231,074
246,665
287,345
404,000
404,000287,345246,665231,074221,815212,180189,412168,146149,500145,871120,37391,28063,30538,71913,0004,0763,647193,514203,993192,031170,607172,724171,883152,0940
   Retained Earnings Total Equity0000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
-17,419
-2,021
-3,951
-3,591
-246
-53,868
3,349
12,499
84,103
89,852
100,821
86,033
61,238
58,548
45,644
81,336
90,004
139,021
60,152
223,075
219,803
233,245
260,100
260,100233,245219,803223,07560,152139,02190,00481,33645,64458,54861,23886,033100,82189,85284,10312,4993,349-53,868-246-3,591-3,951-2,021-17,41900
   Capital Surplus 0000000000000000000000000
   Treasury Stock000-2,200-3,600-1,800-3,000-1,662-2,3940000000000000000
   Other Stockholders Equity 
0
0
-171,883
2,021
3,951
3,591
246
53,868
0
0
0
0
0
-3,070
-3,118
-3,086
-2,161
-1,523
-2,821
-1,728
-3,487
-2,023
-123,849
-112,260
0
0-112,260-123,849-2,023-3,487-1,728-2,821-1,523-2,161-3,086-3,118-3,0700000053,8682463,5913,9512,021-171,88300



5.3. Balance Sheets

Currency in NZD. All numbers in thousands.